Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures (QoQ) (2015 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures (QoQ) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 100.47% |
| Mar 31, 2024 | -2,036.36% |
| Dec 31, 2023 | -76.09% |
| Mar 31, 2022 | -75.17% |
| Dec 31, 2020 | -191.70% |
| Sep 30, 2020 | 251.17% |
| Jun 30, 2020 | -96.51% |
| Mar 31, 2020 | -64.10% |
| Dec 31, 2019 | 8.15% |
| Sep 30, 2019 | 537.10% |
| Jun 30, 2019 | 169.86% |
| Mar 31, 2019 | 103.39% |
| Dec 31, 2018 | -2,037.19% |
| Sep 30, 2018 | -92.64% |
| Jun 30, 2018 | 183.00% |
| Mar 31, 2018 | -1.34% |
| Jun 30, 2017 | -37.97% |
| Mar 31, 2017 | 99.58% |
| Dec 31, 2016 | 111.61% |
| Sep 30, 2016 | -242.13% |